Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: Long-term results and findings affecting outcome

Surgical Endoscopy

Volumn 26, Issue 5, 2012, Pages 1425-1435

  Testoni, Pier Alberto ^a   Vailati, Cristian ^a   Testoni, Sabrina ^a   Corsetti, Maura ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Gastroesophageal reflux disease; Transoral incisionless fundoplication

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG USE; DRUG WITHDRAWAL; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HIATUS HERNIA; HUMAN; MALE; PH; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; RISK FACTOR; STOMACH FUNDOPLICATION; SURGICAL EQUIPMENT; SURGICAL FASTENER; TRANSORAL INCISIONLESS FUNDOPLICATION; TREATMENT OUTCOME;

EID: 84863513510     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-011-2050-1     Document Type: Article

References (35)

1. Cadière GB, Rajan A, Rquibate M, Germay O, Dapri G, Himpens J, Gawlicka AK (2006) Endoluminal Fundoplication (ELF)- evolution of EsophyX TM , a new surgical device for transoral surgery. Minim Invasive Ther Allied Technol 15:348-355
2. Bell RC, Cadière GB (2010) Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. doi:10.1007/s00464-010-1528-6
3. Cadiere GB, Rajan A, Germay O, Himpens J (2008) Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc 22:333-342
4. Cadiere GB, Buset M, Muls V, Rajan A, Rösch T, Eckardt AJ, Weerts J, Bastens B, Costamagna G, Marchese M, Louis H, Mana F, Sermon F, Gawlicka AK, Daniel MA, Devière J (2008) Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 32:1676-1688
5. Cadiere GB, Van Sante N, Graves JE, Gawlicka AK, Rajan A (2009) Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using Esophyx. Surg Endosc 23:957-964
6. Testoni PA, Corsetti M, Di Pietro S, Castellaneta AG, Vailati C, Masci E, Passaretti S (2010) Effect of transoral incisionless fundoplication on symptoms, PPI use, and pH-impedance refluxes of GERD patients. World J Surg 34(4):750-757
7. Demyttenaere SV, Bergman S, Pham T, Anderson J, Dettorre R, Melvin WS, Mikami DJ (2010) Transoral incisionless fundoplication for gastro-esophageal reflux disease in an unselected patient population. Surg Endosc 24:854-858
8. Repici A, Fumagalli U, Malesci A, Barbera R, Gambaro C, Rosati R (2010) Endoluminal fundoplication (ELF) for GERD using Esophyx: a 12-month follow-up in a single-center experience. J Gastrointest Surg 14:1-6
9. Bell RC, Freeman KD (2010) Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc. doi:10.1007/s00464-010-1497-9
10. Triadafilopoulos G (2007) Endotherapy and Surgery for GERD. J Clin Gastroenterol 41(Suppl 2):S87-S96
11. Portale G, Filipi CJ, Peters JH (2004) A current assessment of endoluminal approaches to the treatment of gastroesophageal reflux disease. Surg Innov 4:225-234
12. Fry LC, Monkenmuller K, Malfertheiner P (2007) Systematic review: endoluminal therapy for gastro-oesophageal reflux disease: evidence from clinical trials. Eur J Gastroenterol Hepatol 19: 1125-1139
13. Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130:1377-1390
14. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles Classification. Gut 45:172-180
15. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217-224
16. Raymond JM, Marquis P, Bechade D, Smith D, Mathiex Fortunet H, Poynard T, Galmiche JP, Amouretti M (1999) Assessment of quality of life of patients with gastroesophageal reflux. Elaboration and validation of a specific questionnaire. Gastroenterol Clin Biol 23:32-39
17. Jobe BA, Kahrilas PJ, Vernon AH, Sandone C, Gopal DV, Swanstrom LL, Aye RW, Hill LD, Hunter JG (2004) Endoscopic appraisal of the gastroesophageal valve after antireflux surgery. Am J Gastroenterol 99:233-243
18. Jobe BA, O'Rourke RW, McMahon BP, Gravesen F, Lorenzo C, Hunter JG, Bronner M, Kraemer SJ (2008) Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease. The anatomic and physiologic basis for reconstruction of the esophago-gastric junction using a novel device. Ann Surg 248:69-76
19. Hill D, Kozarek RA (1999) The gastroesophageal flap valve. J Clin Gastroenterol 28:194-197
20. Malmud LS, Fischer RS, Knight LC, Rock E (1982) Scintigraphic evaluation of gastric emptying. Semin Nucl Ned 12:116-125
21. Passaretti S, Zaninotto G, Di Martino N, Leo P, Costantini M, Baldi F (2000) Standards for esophageal manometry. A position statement of GISMAD. Dig Liver Dis 32:46-55
22. Spechler SJ, Castell DO (2001) Classification of oesophageal motility abnormalities. Gut 49:145-151
23. Zerbib F, des Varannes SB, Roman S, Pouderoux P, Artigue F, Chaput U, Mion F, Caillol F, Verin E, Bommelaer G, Ducrotté P, Galmiche JP, Sifrim D (2005) Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 22:1011-1021
24. Johnson LF, DeMeester TR (1986) Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol 8:52-58
25. Zagol B, Mikami D (2011) Advances in transoral fundoplication for oesophageal reflux. Dig Liver Dis. doi:10.1016/j.dld.2011. 01.006
26. Lundell L, Miettinen P (2001) Continued (5 years) follow up of a randomized clinical study comparing antireflux surgery and omeprazole in GERD. J Am Col Surg 192:171-182
27. Draaisma WE, Rijnhart-de Jong HG, Broeders IAMJ, Smout AJ, Furnee EJ, Gooszen HG (2006) Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication. Ann Surg 244:34-41
28. Smith CD (2009) Surgical therapy for gastroesophageal reflux disease: indications, evaluation and procedures. Gastrointest Endoscopy Clin North Am 19:35-48
29. Broeders JA, Draaisma WA, Bredenoord AJ, Smout AJ, Broeders IA, Gooszen HG (2010) Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-esophageal reflux disease. Br J Surg 97:845-852
30. Velanovich V (2010) Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned. Surgery. doi:10.1016/j.surg.2010.07.031
31. Barnes WE, Hoddinott KM, Mundy S, Williams M (2011) Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov. doi: 10.1177/1553350610392067
32. Hoppo T, Immanuel A, Schuchert M, Dubrava Z, Smith A, Nottle P, Watson DI, Jobe BA (2010) Transoral incisionless fundoplication 2.0 procedure using EsophyX TM for gastroesophageal reflux disease. J Gastrointest Surg. doi:10.1007/s11605-010-1331-7
33. Richter JE (2007) The many manifestations of gastro-esophageal reflux disease: presentation, evaluation, and treatment. Gastroenterol Clin North Am 36:577-599
34. Kim KY, Kim GH, Kim DU, Wang SG, Lee BJ, Lee JC, Park DY, Song GA (2008) Is ineffective esophageal motility associated with gastropharyngeal reflux disease? World J Gastroenterol 14:6030-6035
35. Haack HG, Hansen RD, Malcolm A, Kellow JE (2008) Ineffective oesophageal motility: manometric subsets exhibit different symptom profiles. World J Gastroenterol 14:3719-3724